Skip to main content

Idamycin PFS

NDC 0013-2596 · Pfizer Laboratories Div Pfizer Inc

Generic nameidarubicin hydrochloride
Dosage formSOLUTION
RouteINTRAVENOUS
Active ingredient(s)IDARUBICIN HYDROCHLORIDE
Strength1 mg/mL
Pharmacologic classAnthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA]
Marketing categoryNDA

Packages

0013-2596-20 — 1 VIAL, SINGLE-DOSE in 1 CARTON (0013-2596-20) / 20 mL in 1 VIAL, SINGLE-DOSE

Billed under HCPCS

J9211 — Injection, idarubicin hydrochloride, 5 mg Medicare Part B payment limit (ASP + 6%): $38.13

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0013-2576 — idarubicin hydrochloride, 0013-2586 — idarubicin hydrochloride, 0143-9217 — Idarubicin Hydrochloride, 0143-9218 — Idarubicin Hydrochloride, 0143-9219 — Idarubicin Hydrochloride, 0143-9306 — Idarubicin Hydrochloride, 0143-9307 — Idarubicin Hydrochloride, 0143-9308 — Idarubicin Hydrochloride, 71288-184 — Idarubicin Hydrochloride, 71288-185 — Idarubicin Hydrochloride, 71288-186 — Idarubicin Hydrochloride

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels